Deal title

Principal company

Partner company

Total projected at signing (US$M)

Technologies

Date announced


Ravenquest acquires a majority stake in Alberta Green Biotech

Alberta Green Biotech Inc.

Ravenquest Biomed Inc.

Payment Unspecified

Small-molecule therapeutic

5/25/17

KBI to acquire Alliance Protein Laboratories

Alliance Protein Laboratories

KBI Biopharma Inc.

Payment Unspecified

Biosimilar product; gene transfer system; monoclonal antibody; peptide

6/15/17

Nantcell to acquire Altor Bioscience

Altor Bioscience Corp.

Nantcell Inc.

Payment Unspecified

Small-molecule therapeutic

6/27/17

Aviragen to merge with Vaxart

Aviragen Therapeutics Inc.

Vaxart Inc.

$1.75

Small-molecule therapeutic

10/27/17

Creat Group to acquire Biotest

Biotest AG

Creat Group Corp.

$1,300.00

Small-molecule therapeutic

3/29/17

CSL Behring to acquire Calimmune

Calimmune Inc.

CSL Ltd.

$416.00

Stem cell therapy;
autologous stem cell
therapy; biological
therapeutic; haematopoietic
stem cell therapy

8/28/17

Protext Mobility acquires Cannabis Biosciences

Cannabis Biosciences Inc.

Protext Mobility Inc.

Payment Unspecified

Small-molecule therapeutic

3/27/17

Sevion to acquire Eloxx Pharmaceuticals

Eloxx Pharmaceuticals Ltd.

Sevion Therapeutics Inc.

Payment Unspecified

Small-molecule therapeutic

5/31/17

Nulife to sign letter of intent to acquire Ensysce Biosciences

Ensysce Biosciences Inc.

Nulife Sciences Inc.

Payment Unspecified

Small-molecule therapeutic

10/25/17

Espero and Armetheon to merge to form a new company Espero Biopharma

Espero Biopharma Inc.

Armetheon Inc.

Payment Unspecified

Small-molecule therapeutic

3/30/17

Neothetics to merge with Evofem

Evofem Biosciences

Neothetics Inc.

Payment Unspecified

Small-molecule therapeutic

10/17/17

Nupharm to acquire FB Health

FB Health

Nupharm Italy SpA

Payment Unspecified

Small-molecule therapeutic

6/19/17

Winston entered into letter of intent to acquire GT Therapeutics

Green Tree Therapeutics LLC

Winston Resources LLC

$25.12

Small-molecule therapeutic

2/24/17

Dance Biopharm to purchase Harmony Biopharm

Harmony Biopharm Ltd.

Dance Biopharm Inc.

Payment Unspecified

Protein recombinant

8/29/17

Kangen Pharmaceuticals to acquire KC Specialty Therapeutics

KC Specialty Therapeutics LLC

Kangen Pharmaceuticals Co. Ltd.

Payment Unspecified

Small-molecule therapeutic

12/13/17

Gilead Sciences acquires Kite Pharma

Kite Pharma Inc.

Gilead Sciences Inc.

$12,256.00

Cell therapy

8/27/17

Ethypharm to acquire Martindale

Martindale Pharma

Ethypharm SA

Payment Unspecified

Small-molecule therapeutic

1/19/17

Astellas to acquire Mitobridge

Mitobridge Inc.

Astellas Pharma Inc.

$450.00

Small-molecule therapeutic

11/30/17

Immunoprecise Antibodies entered into letter of intent to acquire Modiquest

Modiquest BV

Immunoprecise Antibodies Ltd.

$8.23

Monoclonal antibody human

12/7/17

Otsuka Pharmaceutical to acquire Neurovance

Neurovance Inc.

Otsuka Pharmaceutical Co. Ltd.

$250.00

Small-molecule therapeutic

3/2/17

Black Beret to acquire Okyanos

Okyanos Operating Company Ltd.

Black Beret Life Sciences LLC

Payment Unspecified

Stem cell therapy

7/25/17

Hitachi Chemical acquires PCT

PCT, a Caladrius
company

Hitachi Chemical Co. America Ltd.

$80.00

Biological therapeutic

11/27/17

Skinvisible to enter a non-binding term sheet to merge with Quoin Pharmaceuticals

Quoin Pharmaceuticals Ltd.

Skinvisible Inc.

Payment Unspecified

Oligonucleotide

9/6/17

Merck to acquire Rigontec

Rigontec GmbH

Merck & Co. Inc.

$552.30

Small-molecule therapeutic

7/24/17

Briacell to acquire Sapientia Pharmaceuticals

Sapientia Pharmaceuticals Inc.

Briacell Therapeutics Corp.

Payment Unspecified

Generic product; biosimilar product

5/11/17

Nidda Healthcare to acquire Stada Arzneimittel

Stada Arzneimittel AG

Nidda Healthcare Holding AG

Payment Unspecified

Oligonucleotide; biological therapeutic; immuno-oncology

11/1/17

Mitsubishi Tanabe to acquire Stelic Institute

Stelic Institute & Co.

Mitsubishi Tanabe Pharma Corp.

$104.79

Small-molecule therapeutic

10/11/17

Lupin acquires Symbiomix Therapeutics

Symbiomix Therapeutics LLC

Lupin Pharmaceuticals Inc.

Unknown

Oligonucleotide

1/9/17

Fountain Biopharma to merge with Synovel Sciences

Synovel Sciences Inc.

Fountain Biopharma Inc.

Payment Unspecified

Chimeric monoclonal
antibody

3/16/17


Notes

Source: Cortellis Deals Intelligence

* This chart includes pending mergers and acquisitions announced within the past year.